
Tim Collins joins us to discuss the index behind the PSYK ETF which is comprised of companies in the research, development, and production of psychedelics to help treat a wide variety of mental illnesses. While psychedelic drugs have been around for millenniums, he believes that we are on the cusp of realizing their true potential to disrupt the psychiatric medical field.
Visit Us @: www.exchangetradedconcepts.com